AstraZeneca: US Data Shows Vaccine Effective For All Adults

FILE - In this Friday, March 19, 2021 file photo Medical staff members administer the AstraZeneca vaccine at La Nuvola (The Cloud) convention center that was temporarily turned into a COVID-19 vaccination hub, in Rome. AstraZeneca said Monday March 22, 2021 that advanced trial data from a U.S. study on its COVID vaccine shows it is 79% effective. The U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. (AP Photo/Gregorio Borgia)

(AP) — AstraZeneca says its COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease in final-stage U.S. testing, including in older adults.

AstraZeneca said Monday that its experts did not identify any safety concerns related to the vaccine, including finding no increased risk of rare blood clots identified in Europe. The question now is whether the findings will help rebuild public confidence in the vaccine around the world, as the company seeks to win clearance in the U.S.

In a statement, AstraZeneca said its COVID-19 vaccine was 79% effective at preventing symptomatic COVID-19 and was 100% effective in stopping severe disease and hospitalization, though it has not yet published full data.


Germany Looks Set To Extend Virus Lockdown Measures Again

Previous article

Fox Weather Forecaster Dean Turns Into Fierce Cuomo Critic

Next article

You may also like

More in WORLD